Patients receiving adjuvant chemotherapy will need more dose adjustments to avoid toxicity than those recommended in protocols based on unrealistic clinical trials, a review shows. In real world practice many chemotherapy patients are having higher rates of treatment-related toxicity than the carefully selected and monitored participants in clinical trials, according to a review of evidence ...
Why we need to talk more about chemotherapy toxicity and dose adjustment
By Michael Woodhead
13 Mar 2018